Guinea vs Kenya: Population requiring preventive chemotherapy for schistosomiasis
Guinea
4.21 million
in 2024
Kenya
4.77 million
in 2024
Guinea rank
20th
Kenya rank
18th
Population requiring preventive chemotherapy for schistosomiasis over time
- Guinea
- Kenya
How they compare
Kenya currently reports 4.77 million against 4.21 million in Guinea, a difference of 557,430.
That makes Kenya's figure about 1.1 times Guinea's.
The two have swapped places 2 times across 15 shared years of data; in 2010 it was Kenya ahead.
Guinea ranks 20th and Kenya ranks 18th of 52 countries.
Across the 2 decades both report, Guinea averaged higher in 1 and Kenya in 1.
Head to head by decade
| Decade | Guinea | Kenya | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.98 million | 6.35 million | 3.36 million | Kenya |
| 2020s | 4.42 million | 4.24 million | 181,768 | Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Guinea or Kenya?
- Kenya, at 4.77 million against 4.21 million in Guinea as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Guinea and Kenya?
- 557,430, with Kenya ahead.
- How many years of comparable data are there for Guinea and Kenya?
- 15 years are reported by both, from 2010 to 2024.
- How do Guinea and Kenya rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Guinea ranks 20th and Kenya ranks 18th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.